NF1 and breast carcinoma: Furthermore, these findings may be applicable to a wider variety of cancers, as neurofibromin loss is found in breast cancer; gastrointestinal stromal tumors; neuroblastomas; rhabdomyosarcoma; and juvenile myelomonocytic leukemia; and others [32].